US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

ONCO

Onconetix (ONCO)

Onconetix Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ONCO

Fecha	Hora	Fuente	Título	Símbolo	Compañía
17/12/2024	05:03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ONCO	Onconetix Inc
12/12/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ONCO	Onconetix Inc
12/12/2024	16:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ONCO	Onconetix Inc
12/12/2024	16:00	GlobeNewswire Inc.	Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing	NASDAQ:ONCO	Onconetix Inc
11/12/2024	16:11	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:ONCO	Onconetix Inc
11/12/2024	05:24	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ONCO	Onconetix Inc
15/11/2024	10:25	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:ONCO	Onconetix Inc
15/11/2024	09:45	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ONCO	Onconetix Inc
01/11/2024	16:06	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ONCO	Onconetix Inc
01/11/2024	15:56	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:ONCO	Onconetix Inc
31/10/2024	15:20	Edgar (US Regulatory)	Form DEF 14C - Other definitive information statements	NASDAQ:ONCO	Onconetix Inc
18/10/2024	15:10	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	NASDAQ:ONCO	Onconetix Inc
17/10/2024	10:53	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ONCO	Onconetix Inc
09/10/2024	16:16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ONCO	Onconetix Inc
03/10/2024	15:45	GlobeNewswire Inc.	Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit	NASDAQ:ONCO	Onconetix Inc
03/10/2024	08:05	GlobeNewswire Inc.	Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit	NASDAQ:ONCO	Onconetix Inc
01/10/2024	15:35	Edgar (US Regulatory)	Form SC 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:ONCO	Onconetix Inc
30/09/2024	18:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ONCO	Onconetix Inc
27/09/2024	14:54	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ONCO	Onconetix Inc
26/09/2024	15:08	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ONCO	Onconetix Inc
26/09/2024	05:16	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ONCO	Onconetix Inc
20/09/2024	10:45	GlobeNewswire Inc.	Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders	NASDAQ:ONCO	Onconetix Inc
03/09/2024	14:11	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ONCO	Onconetix Inc
29/08/2024	06:38	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ONCO	Onconetix Inc
01/08/2024	15:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ONCO	Onconetix Inc
22/07/2024	16:00	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:ONCO	Onconetix Inc
15/07/2024	05:00	GlobeNewswire Inc.	Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds	NASDAQ:ONCO	Onconetix Inc
11/07/2024	07:17	GlobeNewswire Inc.	Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds	NASDAQ:ONCO	Onconetix Inc
13/02/2024	05:00	GlobeNewswire Inc.	Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors	NASDAQ:ONCO	Onconetix Inc
18/12/2023	06:00	GlobeNewswire Inc.	Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™	NASDAQ:ONCO	Onconetix Inc

Showing the most relevant articles for your search:NASDAQ:ONCO

American Express

Financial Select Sector

Bank of America

Gold vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones